Calmasol-440, solution for infusion for cattle, sheep and pigs
Calmasol-440, solution for infusion for cattle, sheep and pigs
Authorised
- Calcium gluconate monohydrate
- Magnesium chloride hexahydrate
- Boric acid
Product identification
Medicine name:
Calmasol-440, solution for infusion for cattle, sheep and pigs
Calmafusion Oplossing voor infusie
Calmafusion Solution pour perfusion
Calmafusion Infusionslösung
Active substance:
- Calcium gluconate monohydrate
- Magnesium chloride hexahydrate
- Boric acid
Target species:
-
Cattle
-
Sheep
-
Pig
Route of administration:
-
Intravenous use
Product details
Active substance and strength:
-
Calcium gluconate monohydrate380.00milligram(s)1.00millilitre(s)
-
Magnesium chloride hexahydrate60.00milligram(s)1.00millilitre(s)
-
Boric acid50.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for infusion
Withdrawal period by route of administration:
-
Intravenous use
- Cattle
-
Meat and offal0day
-
Milk0hour
-
- Sheep
-
Meat and offal0day
-
Milk0hour
-
- Pig
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA12AX
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Graduated polypropylene bottle, closed with a bromobutyl rubber stopper and secured with an aluminium cap. 12x500 ml.
- Graduated polypropylene bottle, closed with a bromobutyl rubber stopper and secured with an aluminium cap. 1x500 ml.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Interchemie Werken De Adelaar Eesti AS
Marketing authorisation date:
Manufacturing sites for batch release:
- Interchemie Werken De Adelaar Eesti AS
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V549697
Date of authorisation status change:
Reference member state:
-
Estonia
Procedure number:
- EE/V/0104/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: